![]()
TITLE 21
READY-TO-GO CMC SERIES
GENERIC DRUG DEVELOPMENT CMC KNOWHOW
Contents of a Ready-To-Go
Dossier
| RTG | DRUG PRODUCT | FORM | Strength | USD | eFile (Ab) |
| 99 | Silver Sulphadiazine | Cream | 1% |
A | 1/3 of A |
| 100 | Tamoxifen EU Aqueous Coated | Tablets | 10 / 20 mg |
B |
1/3 of B |
| 101 | Tamoxifen EU Aqueous Coated | Tamoxifen EU | 30 / 40mg |
C
|
1/3 of C
|
| 102 | Tamoxifen US Aqueous Coated | Tablets | 10/20/40mg |
B |
1/3 of B |
| 103 | Tamoxifen US Non Coated | Tablets | 10/20/40mg |
B |
1/3 of B |
| 104 | Terbutaline Sulfate | Syrup | 0.3 mg/mL |
B |
1/3 of B |
| 105 | Terazosin US/EU | Tablets | 1mg / 2mg |
B |
1/3 of B |
| 106 | Terfenazine US/EU | Tablets | 60 mg |
B |
1/3 of B |
| 107 | Tetrahydrozoline HCl USP | Eye Drops | 2,5mg/5mL |
B |
1/3 of B |
| 108 | Ticlopidine US/EU | Tablets | 250 mg |
B |
1/3 of B |
| 109 | Timolol maleate Drops USP | Eye Drops | 0.25 / 0.5% |
C
|
1/3 of C
|
| 110 | Tolmetin Sod. US/EU | Capsules | 400 mg |
B |
1/3 of B |
| 111 | Tolmetin Sod. US/EU | Tablets | 600 mg |
B |
1/3 of B |
| 112 | Trazodone US/EU | Tablets | 50/100 mg |
C
|
1/3 of C
|
| 113 | Trazodone US/EU | Tablets | 150 mg |
C
|
1/3 of C
|
| 114 | Tretinoin | Cream USP | 0.025% 0.05% |
C
|
1/3 of C
|
| 115 | Sulfamethoxazole Trimethoprim | Tablets USP | 80/400mg |
B |
1/3 of B |
| 116 | Sulfamethoxazole Trimethoprim DS | Tablets USP | 160/800mg |
C
|
1/3 of C
|
| 117 | Sulfamethoxazole Trimethoprim | Suspension | 80/400mg |
B |
1/3 of B |
| 118 | Sodium Valproate | Syrup | 4 / 8 /mg |
B |
1/3 of B |
| 119 | Verapamil Hydrochloride | Tablets | 40/80/120mg |
C
|
1/3 of C
|
| [List 1] [List 2] [List 3] [List 4] [List 5] | |||||
NOTE : EULA and IAGIM Rules / Regulations apply to Ready-To-Go CMC Series |
| Title 21 Ready-To-Go Price Range - US Dollars $ value (Extended Benefit Plans) | ||
| A - $2999 - $3499 USD | B - USD $2999 - $3999 | C - USD $3999 - $4999 |
| D - USD $4500 - $4999 | E - USD $5000 - $6999 | SP - USD $7000 - $7990 |
| Abbreviated Title 21 e-files reduce file cost by 66% of full content print files |

![]()
![]()
![]()
WELCOME
| JOURNALS | HANDBOOKS
| IAGIM | IAGIM
ONLINE | What's NEW | CONTACT
| LINKS
BOOKSTORE | DOWNLOAD AREA
| ARTICLE of the MONTH
| SPECIAL
| FAQ | CONFERENCES
WORLDWIDE SITES | DRUG
DEVELOPMENT WORK SHOPS | JOBS | CLIENT
PROFILE
CONTACT USA -|--561
865 6147 -|
©
1992-2019/20 Locum International Group. - All Rights Reserved. Web Design
by TheSite - A Division of the LIG.